When does CVS Health report earnings?
CVS Health Corp. · end-of-day data as of Nov 13, 2026
- PT$110.28 +23.4%
- ConsensusBuy · 28
- P/E vs own-67.1%
- P/E vs sector-67.7%
- FCF yield+13.6%
- Insiders$2M
- News
- MA20×50Golden 3d ago
- MACD0.18
- Sector▲ +15.9%
- Earnings in88d
- P/E10.4x
- RSI51
- Support-1.1%
- Resistance+3.1%
- Off 52w high-19.3%
- Volume0.7x
- Bollingerlower half
- 52w range$70–$111
- ATR+3.4%
- Off ATH-21.4%
- MAs2 of 4
- Trendbearish
Updates with the 15-min delayed price. Not a forecast or investment advice.
![]()
The stock around its reports
Last close $89.35 · +72.1% over 2y · E earnings · D dividend · S split · A analyst rating change
Quarterly results
Q3 FY2026: Revenue +5.4% year over year, free cash flow 3.6% of revenue, operating margin 3.3%.
| Q3 FY2026 | Sep 30, 2026 | $108B | 1.68 | $3.91B | 13.7% | 3.3% | 2.0% |
| Q2 FY2026 | Jun 30, 2026 | $106B | 2.31 | $5.65B | 14.8% | 4.4% | 2.8% |
| Q1 FY2026 | Mar 31, 2026 | $100B | 2.30 | $3.4B | 15.6% | 4.7% | 2.9% |
| Q4 FY2025 | Dec 31, 2025 | $106B | 2.30 | $2.61B | 12.8% | 2.0% | 2.8% |
| Q3 FY2025 | Sep 30, 2025 | $103B | -3.13 | $98M | 13.4% | -3.1% | -3.9% |
| Q2 FY2025 | Jun 30, 2025 | $98.92B | 0.80 | $1.29B | 13.7% | 2.4% | 1.0% |
| Q1 FY2025 | Mar 31, 2025 | $94.59B | 1.41 | $3.81B | 15.2% | 3.6% | 1.9% |
| Q4 FY2024 | Dec 31, 2024 | $97.71B | 1.30 | $1.09B | 13.2% | 2.4% | 1.7% |